-
1
-
-
0028227994
-
A longitudinal analysis of the association between menopause and depression: Results from the Massachusetts Women's Health Study
-
Avis NE, Brambilla D, McKinlay SM, et al. A longitudinal analysis of the association between menopause and depression: results from the Massachusetts Women's Health Study. Ann Epidemiol 1994;4:214-20.
-
(1994)
Ann Epidemiol
, vol.4
, pp. 214-220
-
-
Avis, N.E.1
Brambilla, D.2
McKinlay, S.M.3
-
2
-
-
0036238750
-
Epidemiology of depression throughout the female life cycle
-
Burt VK, Stein K. Epidemiology of depression throughout the female life cycle. J Clin Psychiatry 2002;63(suppl 7):9-15.
-
(2002)
J Clin Psychiatry
, vol.63
, Issue.SUPPL. 7
, pp. 9-15
-
-
Burt, V.K.1
Stein, K.2
-
3
-
-
0031473782
-
Gender differences in depression: Implications for treatment
-
Kornstein SG. Gender differences in depression: implications for treatment. J Clin Psychiatry 1997;58(suppl 15):12-8.
-
(1997)
J Clin Psychiatry
, vol.58
, Issue.SUPPL. 15
, pp. 12-18
-
-
Kornstein, S.G.1
-
4
-
-
0017356624
-
Sex differences and the epidemiology of depression
-
Weissman MM, Klerman GL. Sex differences and the epidemiology of depression. Arch Gen Psychiatry 1977;34:98-111.
-
(1977)
Arch Gen Psychiatry
, vol.34
, pp. 98-111
-
-
Weissman, M.M.1
Klerman, G.L.2
-
5
-
-
34247951940
-
The relationship between sex, marital status, and mental illness
-
Gove WR. The relationship between sex, marital status, and mental illness. Soc Forces 1972;51:34-44.
-
(1972)
Soc Forces
, vol.51
, pp. 34-44
-
-
Gove, W.R.1
-
6
-
-
0034016323
-
Menopause across cultures: A review of the evidence
-
Makhlouf Obermeyer C. Menopause across cultures: a review of the evidence. Menopause 2000;7:184-92.
-
(2000)
Menopause
, vol.7
, pp. 184-192
-
-
Obermeyer, C.M.1
-
7
-
-
0033304765
-
Estrogen action in the central nervous system
-
McEwen BS, Alves SE. Estrogen action in the central nervous system. Endocrinol Rev 1999;20:279-307.
-
(1999)
Endocrinol Rev
, vol.20
, pp. 279-307
-
-
McEwen, B.S.1
Alves, S.E.2
-
8
-
-
0030918340
-
Role of estrogen in postmenopausal depression
-
Halbreich U. Role of estrogen in postmenopausal depression. Neurology 1997;48(suppl 7): S16-20.
-
(1997)
Neurology
, vol.48
, Issue.SUPPL. 7
-
-
Halbreich, U.1
-
9
-
-
0028940882
-
Estrogen augments serotonergic activity in postmenopausal women
-
Halbreich U, Rojansky N, Palter S, et al. Estrogen augments serotonergic activity in postmenopausal women. Biol Psychiatry 1995;37:434-41.
-
(1995)
Biol Psychiatry
, vol.37
, pp. 434-441
-
-
Halbreich, U.1
Rojansky, N.2
Palter, S.3
-
10
-
-
0023256483
-
Upregulation of imipramine binding and serotonin reuptake by estradiol in female rat brain
-
Rehavi M, Sepcuti H, Weizman A. Upregulation of imipramine binding and serotonin reuptake by estradiol in female rat brain. Brain Res 1987;410:135-9.
-
(1987)
Brain Res
, vol.410
, pp. 135-139
-
-
Rehavi, M.1
Sepcuti, H.2
Weizman, A.3
-
11
-
-
0027314886
-
Blood serotonin levels in postmenopausal women: Effects of age and serum oestradiol levels
-
Gonzales GF, Carillo C. Blood serotonin levels in postmenopausal women: effects of age and serum oestradiol levels. Maturitas 1993;17:23-9.
-
(1993)
Maturitas
, vol.17
, pp. 23-29
-
-
Gonzales, G.F.1
Carillo, C.2
-
12
-
-
0018388568
-
Estrogen therapy for severe persistent depression in women
-
Klaiber EL, Broverman DM, Vogel W, et al. Estrogen therapy for severe persistent depression in women. Arch Gen Psychiatry 1979;36:550-4.
-
(1979)
Arch Gen Psychiatry
, vol.36
, pp. 550-554
-
-
Klaiber, E.L.1
Broverman, D.M.2
Vogel, W.3
-
13
-
-
0030455839
-
The effect of estrogen replacement therapy on plasma serotonin and catecholamines of postmenopausal women
-
Blum I, Vered Y, Lifshitz A, et al. The effect of estrogen replacement therapy on plasma serotonin and catecholamines of postmenopausal women. Isr J Med Sci 1996;32:1158-62.
-
(1996)
Isr J Med Sci
, vol.32
, pp. 1158-1162
-
-
Blum, I.1
Vered, Y.2
Lifshitz, A.3
-
14
-
-
0026096541
-
Induction of hypothalamic opioid activity with transdermal estradiol administration in postmenopausal women
-
D'Amico JF, Greendale GA, Lu JK, et al. Induction of hypothalamic opioid activity with transdermal estradiol administration in postmenopausal women. Fertil Steril 1991;55:754-8.
-
(1991)
Fertil Steril
, vol.55
, pp. 754-758
-
-
D'Amico, J.F.1
Greendale, G.A.2
Lu, J.K.3
-
15
-
-
0036774029
-
Critical appraisal of effects of estrogen replacement therapy on symptoms of depressed mood
-
Stoppe G, Doren M. Critical appraisal of effects of estrogen replacement therapy on symptoms of depressed mood. Arch Womens Ment Health 2002;5:39-47.
-
(2002)
Arch Womens Ment Health
, vol.5
, pp. 39-47
-
-
Stoppe, G.1
Doren, M.2
-
16
-
-
0025906739
-
The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women
-
Sherwin BB. The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women. J Clin Endocrinol Metab 1991;72:336-43.
-
(1991)
J Clin Endocrinol Metab
, vol.72
, pp. 336-343
-
-
Sherwin, B.B.1
-
17
-
-
0033532547
-
Androgen treatment in women
-
Davis SR. Androgen treatment in women. Med J Aust 1999;170:545-9.
-
(1999)
Med J Aust
, vol.170
, pp. 545-549
-
-
Davis, S.R.1
-
18
-
-
0027332652
-
Clinical recognition and management of depression in node negative breast cancer patients treated with tamoxifen
-
Cathcart CK, Jones SE, Pumroy CS, et al. Clinical recognition and management of depression in node negative breast cancer patients treated with tamoxifen. Breast Cancer Res Treat 1993;27:277-81.
-
(1993)
Breast Cancer Res Treat
, vol.27
, pp. 277-281
-
-
Cathcart, C.K.1
Jones, S.E.2
Pumroy, C.S.3
-
19
-
-
0033764796
-
Depressive mood symptoms associated with ovarian suppression
-
Warnock JK, Bundren JC, Moris DW. Depressive mood symptoms associated with ovarian suppression. Fertil Steril 2000;74:984-6.
-
(2000)
Fertil Steril
, vol.74
, pp. 984-986
-
-
Warnock, J.K.1
Bundren, J.C.2
Moris, D.W.3
-
20
-
-
0037028766
-
Quality-of-life and depressive symptoms in postmenopausal women receiving hormone therapy
-
Hlatky MA, Boothroyd D, Vittinghoff E, et al. Quality-of-life and depressive symptoms in postmenopausal women receiving hormone therapy. JAMA 2002;287:591-7.
-
(2002)
JAMA
, vol.287
, pp. 591-597
-
-
Hlatky, M.A.1
Boothroyd, D.2
Vittinghoff, E.3
-
21
-
-
0012868624
-
Effects of estrogen plus progestin on health-related quality of life
-
Hays J, Ockene JK, Brunner RL, et al. Effects of estrogen plus progestin on health-related quality of life. N Engl J Med 2003;348:1839-54.
-
(2003)
N Engl J Med
, vol.348
, pp. 1839-1854
-
-
Hays, J.1
Ockene, J.K.2
Brunner, R.L.3
-
22
-
-
0029645971
-
Prophylactic estrogen in recurrent postpartum affective disorder
-
Sichel DA, Cohen LS, Robertson LM, et al. Prophylactic estrogen in recurrent postpartum affective disorder. Biol Psychiatry 1995;38:814-8.
-
(1995)
Biol Psychiatry
, vol.38
, pp. 814-818
-
-
Sichel, D.A.1
Cohen, L.S.2
Robertson, L.M.3
-
23
-
-
0029880327
-
Transdermal oestrogen for treatment of severe postnatal depression
-
Gregoire AJP, Kumar R, Everitt B, et al. Transdermal oestrogen for treatment of severe postnatal depression. Lancet 1996;347:930-3.
-
(1996)
Lancet
, vol.347
, pp. 930-933
-
-
Gregoire, A.J.P.1
Kumar, R.2
Everitt, B.3
-
24
-
-
0034971361
-
Estrogen deficiency in severe postpartum depression. Successful treatment with sublingual physiologic 17â-Estradiol: A preliminary study
-
Ahokas A, Kaukoranta J, Wahlbeck K, et al. Estrogen deficiency in severe postpartum depression. Successful treatment with sublingual physiologic 17â-Estradiol: a preliminary study. J Clin Psychiatry 2001;62:332-6.
-
(2001)
J Clin Psychiatry
, vol.62
, pp. 332-336
-
-
Ahokas, A.1
Kaukoranta, J.2
Wahlbeck, K.3
-
25
-
-
0030739578
-
A meta-analysis of the effect of hormone replacement therapy upon depressed mood
-
Zweifel JE, O'Brien WH. A meta-analysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrinology 1997;22:189-212.
-
(1997)
Psychoneuroendocrinology
, vol.22
, pp. 189-212
-
-
Zweifel, J.E.1
O'Brien, W.H.2
-
26
-
-
0035013748
-
Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women
-
Soares CN, Almeida OP, Joffe H, et al. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women. Arch Gen Psychiatry 2001;58:529-34.
-
(2001)
Arch Gen Psychiatry
, vol.58
, pp. 529-534
-
-
Soares, C.N.1
Almeida, O.P.2
Joffe, H.3
-
27
-
-
0033836444
-
Estrogen replacement in perimenopause-related depression: A preliminary report
-
Schmidt PJ, Nieman L, Danaceau MA, et al. Estrogen replacement in perimenopause-related depression: a preliminary report. Am J Obstet Gynecol 2000;183:414-20.
-
(2000)
Am J Obstet Gynecol
, vol.183
, pp. 414-420
-
-
Schmidt, P.J.1
Nieman, L.2
Danaceau, M.A.3
-
28
-
-
0036842772
-
Mood symptoms and cognitive performance in women estrogen users and men
-
Miller KJ, Conney JC, Rasgon NL, et al. Mood symptoms and cognitive performance in women estrogen users and men. J Am Geriatr Soc 2002;50:1826-30.
-
(2002)
J Am Geriatr Soc
, vol.50
, pp. 1826-1830
-
-
Miller, K.J.1
Conney, J.C.2
Rasgon, N.L.3
-
29
-
-
0026748884
-
Estrogen use and depressive symptoms in postmenopausal women
-
Palinkas LA, Barrett-Connor E. Estrogen use and depressive symptoms in postmenopausal women. Obstet Gynecol 1992;80:30-6.
-
(1992)
Obstet Gynecol
, vol.80
, pp. 30-36
-
-
Palinkas, L.A.1
Barrett-Connor, E.2
-
30
-
-
0033851372
-
Postmenopausal estrogen therapy and depressive symptoms in older women
-
Whooley MA, Grady D, Cauley JA. Postmenopausal estrogen therapy and depressive symptoms in older women. J Gen Intern Med 2000;15:535-41.
-
(2000)
J Gen Intern Med
, vol.15
, pp. 535-541
-
-
Whooley, M.A.1
Grady, D.2
Cauley, J.A.3
-
31
-
-
3142703442
-
Double blind, placebo controlled, hormonal, syndromal and EEG mapping studies with transdermal estradiol therapy in menopausal depression
-
Saletu B, Brandstatter N, Metka M, et al. Double blind, placebo controlled, hormonal, syndromal and EEG mapping studies with transdermal estradiol therapy in menopausal depression. Psychopharmacology (Berl) 1995;122:321-9.
-
(1995)
Psychopharmacology (Berl)
, vol.122
, pp. 321-329
-
-
Saletu, B.1
Brandstatter, N.2
Metka, M.3
-
32
-
-
0032830125
-
A comparison of estrogen with or without progesterone on mood and physical symptoms in postmenopausal women
-
Girdler SS, O'Briant C, Steege J, et al. A comparison of estrogen with or without progesterone on mood and physical symptoms in postmenopausal women. J Womens Health (Larchmt) 1999;8:637-46.
-
(1999)
J Womens Health (Larchmt)
, vol.8
, pp. 637-646
-
-
Girdler, S.S.1
O'Briant, C.2
Steege, J.3
-
33
-
-
0033013227
-
Adverse events reported by postmenopausal women in controlled trials with raloxifene
-
Davies GC, Huster WJ, Lu Y, et al. Adverse events reported by postmenopausal women in controlled trials with raloxifene. Obstet Gynecol 1999;93:558-65.
-
(1999)
Obstet Gynecol
, vol.93
, pp. 558-565
-
-
Davies, G.C.1
Huster, W.J.2
Lu, Y.3
-
34
-
-
0034734964
-
Raloxifene and estrogen effects on quality of life in healthy postmenopausal women: A placebo-controlled randomized trial
-
Strickler R, Stovall DW, Merritt D, et al. Raloxifene and estrogen effects on quality of life in healthy postmenopausal women: a placebo-controlled randomized trial. Obstet Gynecol 2000;96:359-65.
-
(2000)
Obstet Gynecol
, vol.96
, pp. 359-365
-
-
Strickler, R.1
Stovall, D.W.2
Merritt, D.3
-
35
-
-
0033788486
-
Premenstrual dysphoria and the serotonin system: Pathophysiology and treatment
-
Steiner M, Pearlstein T. Premenstrual dysphoria and the serotonin system: pathophysiology and treatment. J Clin Psychiatry 2000;61(suppl 12):17-21.
-
(2000)
J Clin Psychiatry
, vol.61
, Issue.SUPPL. 12
, pp. 17-21
-
-
Steiner, M.1
Pearlstein, T.2
-
36
-
-
0032851143
-
Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: A randomized controlled trial
-
Freeman EW, Rickels K, Sondheimer SJ, et al. Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: a randomized controlled trial. Arch Gen Psychiatry 1999;56:932-9.
-
(1999)
Arch Gen Psychiatry
, vol.56
, pp. 932-939
-
-
Freeman, E.W.1
Rickels, K.2
Sondheimer, S.J.3
-
37
-
-
0037472875
-
Premenstrual dysphoric disorder
-
Grady-Weliky TA. Premenstrual dysphoric disorder. N Engl J Med 2003;348:433-8.
-
(2003)
N Engl J Med
, vol.348
, pp. 433-438
-
-
Grady-Weliky, T.A.1
-
38
-
-
0029002285
-
Fluoxetine in the treatment of premenstrual dysphoric disorder
-
Steiner M, Steinberg S, Stewart D, et al. Fluoxetine in the treatment of premenstrual dysphoric disorder. N Engl J Med 1995;332:1529-34.
-
(1995)
N Engl J Med
, vol.332
, pp. 1529-1534
-
-
Steiner, M.1
Steinberg, S.2
Stewart, D.3
-
39
-
-
9844253329
-
Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment: A randomized controlled trial
-
Yonkers KA, Halbreich U, Freeman E, et al. Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment: a randomized controlled trial. JAMA 1997; 278:983-8.
-
(1997)
JAMA
, vol.278
, pp. 983-988
-
-
Yonkers, K.A.1
Halbreich, U.2
Freeman, E.3
-
40
-
-
0028897654
-
The serotonin reuptake inhibitor paroxetine is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome
-
Eriksson E, Hedberg MA, Andersch B, et al. The serotonin reuptake inhibitor paroxetine is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome. Neuropsychopharmacology 1995;12:167-76.
-
(1995)
Neuropsychopharmacology
, vol.12
, pp. 167-176
-
-
Eriksson, E.1
Hedberg, M.A.2
Andersch, B.3
-
41
-
-
0031661131
-
Citalopram in premenstrual dysphoria: Is intermittent treatment during luteal phase more effective than continuous medication throughout the menstrual cycle?
-
Wikander I, Sundblad C, Andersch B, et al. Citalopram in premenstrual dysphoria: Is intermittent treatment during luteal phase more effective than continuous medication throughout the menstrual cycle?. J Clin Psychopharmacol 1998;18:390-8.
-
(1998)
J Clin Psychopharmacol
, vol.18
, pp. 390-398
-
-
Wikander, I.1
Sundblad, C.2
Andersch, B.3
-
42
-
-
0031414892
-
Intermittent fluoxetine dosing in the treatment of women with premenstrual dysphoria
-
Steiner M, Korzekwa M, Lamont J, et al. Intermittent fluoxetine dosing in the treatment of women with premenstrual dysphoria. Psychopharmacol Bull 1997;33:771-4.
-
(1997)
Psychopharmacol Bull
, vol.33
, pp. 771-774
-
-
Steiner, M.1
Korzekwa, M.2
Lamont, J.3
-
43
-
-
0030759158
-
Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome
-
Halbreich U, Smoller JW. Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome. J Clin Psychiatry 1997;58:399-402.
-
(1997)
J Clin Psychiatry
, vol.58
, pp. 399-402
-
-
Halbreich, U.1
Smoller, J.W.2
-
44
-
-
0037125379
-
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principle results from the Women's Health Initiative Randomized Controlled Trial
-
Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principle results from the Women's Health Initiative Randomized Controlled Trial. JAMA 2002;288:321-33.
-
(2002)
JAMA
, vol.288
, pp. 321-333
-
-
-
45
-
-
0003433982
-
-
Boston: Harvard School of Public Health, World Health Association, and World Bank
-
Murray CJL, Lopez AD, editors, The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors. Boston: Harvard School of Public Health, World Health Association, and World Bank; 1996.
-
(1996)
The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors
-
-
Murray, C.J.L.1
Lopez, A.D.2
-
46
-
-
0037150109
-
Screening for depression in adults: A summary of the evidence for the US Preventive Services Task Force
-
Pignone MP, Gaynes BN, Rushton JL, et al. Screening for depression in adults: a summary of the evidence for the US Preventive Services Task Force. Ann Intern Med 2002;136:765-76.
-
(2002)
Ann Intern Med
, vol.136
, pp. 765-776
-
-
Pignone, M.P.1
Gaynes, B.N.2
Rushton, J.L.3
-
47
-
-
0037006248
-
All you need is cognitive behavior therapy?
-
Holmes J. All you need is cognitive behavior therapy? BMJ 2002;324:288-94.
-
(2002)
BMJ
, vol.324
, pp. 288-294
-
-
Holmes, J.1
-
48
-
-
0034727820
-
Managing depression in medical outpatients
-
Whooley MA, Simon GE. Managing depression in medical outpatients. N Engl J Med 2000;343:1942-50.
-
(2000)
N Engl J Med
, vol.343
, pp. 1942-1950
-
-
Whooley, M.A.1
Simon, G.E.2
-
49
-
-
0035233551
-
Augmentation and combination therapies in treatment-resistant depression
-
Fava M. Augmentation and combination therapies in treatment-resistant depression. J Clin Psychiatry 2001;62(suppl 18):4-11.
-
(2001)
J Clin Psychiatry
, vol.62
, Issue.SUPPL. 18
, pp. 4-11
-
-
Fava, M.1
-
50
-
-
0033850079
-
Gender differences in treatment response to sertraline versus imipramine in chronic depression
-
Kornstein SG, Schatzberg AF, Thase ME, et al. Gender differences in treatment response to sertraline versus imipramine in chronic depression. Am J Psychiatry 2000;157:1445-52.
-
(2000)
Am J Psychiatry
, vol.157
, pp. 1445-1452
-
-
Kornstein, S.G.1
Schatzberg, A.F.2
Thase, M.E.3
-
51
-
-
0037087582
-
Phase III evaluation of fluoxetine for treatment of hot flashes
-
Loprinzi CL, Sloan JA, Perez EA, et al. Phase III evaluation of fluoxetine for treatment of hot flashes. J Clin Oncol 2002;20:1578-83.
-
(2002)
J Clin Oncol
, vol.20
, pp. 1578-1583
-
-
Loprinzi, C.L.1
Sloan, J.A.2
Perez, E.A.3
-
52
-
-
0033981088
-
A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flushes in breast cancer survivors
-
Stearns V, Isaacs C, Rowland J, et al. A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flushes in breast cancer survivors. Ann Oncol 2000;11:17-22.
-
(2000)
Ann Oncol
, vol.11
, pp. 17-22
-
-
Stearns, V.1
Isaacs, C.2
Rowland, J.3
-
53
-
-
0034676813
-
Venlafaxine in management of hot flashes in survivors of breast cancer: A randomized controlled trial
-
Loprinzi CL, Kugler JW, Sloan JA, et al. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomized controlled trial. Lancet 2000;356:2059-63.
-
(2000)
Lancet
, vol.356
, pp. 2059-2063
-
-
Loprinzi, C.L.1
Kugler, J.W.2
Sloan, J.A.3
-
54
-
-
0034099983
-
Comparison of sertraline and nortriptyline in the treatment of major depressive disorder in late life
-
Bondareff W, Alpert M, Friedhoff AJ, et al. Comparison of sertraline and nortriptyline in the treatment of major depressive disorder in late life. Am J Psychiatry 2000;157:729-36.
-
(2000)
Am J Psychiatry
, vol.157
, pp. 729-736
-
-
Bondareff, W.1
Alpert, M.2
Friedhoff, A.J.3
-
55
-
-
0036232572
-
Prevalence of sexual dysfunction among newer antidepressants
-
Clayton AH, Pradko JF, Croft HA, et al. Prevalence of sexual dysfunction among newer antidepressants. J Clin Psychiatry 2002;63:357-66.
-
(2002)
J Clin Psychiatry
, vol.63
, pp. 357-366
-
-
Clayton, A.H.1
Pradko, J.F.2
Croft, H.A.3
-
56
-
-
0035915312
-
Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: A randomized trial
-
Kroenke K, West SL, Swindle R, et al. Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a randomized trial. JAMA 2001;286:2947-55.
-
(2001)
JAMA
, vol.286
, pp. 2947-2955
-
-
Kroenke, K.1
West, S.L.2
Swindle, R.3
-
57
-
-
0035025833
-
Pharmacology of antidepressants
-
Richelson E. Pharmacology of antidepressants. Mayo Clin Proc 2001;76:511-27.
-
(2001)
Mayo Clin Proc
, vol.76
, pp. 511-527
-
-
Richelson, E.1
-
58
-
-
0242360060
-
Selecting a serotonin reuptake inhibitor: Clinically important distinguishing features
-
Marken PA, Munro JS. Selecting a serotonin reuptake inhibitor: clinically important distinguishing features. J Clin Psychiatry 2000;2:205-10.
-
(2000)
J Clin Psychiatry
, vol.2
, pp. 205-210
-
-
Marken, P.A.1
Munro, J.S.2
-
59
-
-
0035915317
-
Choosing a first-line antidepressant: Equal on average does not mean equal for everyone
-
Simon G. Choosing a first-line antidepressant: equal on average does not mean equal for everyone. JAMA 2001;286:3003-4.
-
(2001)
JAMA
, vol.286
, pp. 3003-3004
-
-
Simon, G.1
-
60
-
-
12644318801
-
Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial
-
Schneider LS, Small GW, Hamilton SH, et al. Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Am J Geriatr Psychiatry 1997;5:97-106.
-
(1997)
Am J Geriatr Psychiatry
, vol.5
, pp. 97-106
-
-
Schneider, L.S.1
Small, G.W.2
Hamilton, S.H.3
-
61
-
-
0034749036
-
Estrogen replacement therapy and antidepressant response to sertraline
-
Schneider LS, Small GW, Clary C. Estrogen replacement therapy and antidepressant response to sertraline. Am J Geriatr Psychiatry 2001;9:393-9.
-
(2001)
Am J Geriatr Psychiatry
, vol.9
, pp. 393-399
-
-
Schneider, L.S.1
Small, G.W.2
Clary, C.3
-
62
-
-
0032875954
-
Fluoxetine efficacy in menopausal woman with and without estrogen replacement
-
Amsterdam J, Garcia-Espana F, Fawcett J, et al. Fluoxetine efficacy in menopausal woman with and without estrogen replacement. J Affect Disord 1999;55:11-7.
-
(1999)
J Affect Disord
, vol.55
, pp. 11-17
-
-
Amsterdam, J.1
Garcia-Espana, F.2
Fawcett, J.3
-
63
-
-
0025865067
-
Long-term treatment of depression
-
Kupfer J. Long-term treatment of depression. J Clin Psychiatry 1991;52(suppl 5):28-34.
-
(1991)
J Clin Psychiatry
, vol.52
, Issue.SUPPL. 5
, pp. 28-34
-
-
Kupfer, J.1
-
65
-
-
0035818277
-
Efficacy of progestogens in management of premenstrual syndrome: A systematic review
-
Wyatt K, Dimmock P, Jones P, et al. Efficacy of progestogens in management of premenstrual syndrome: a systematic review. BMJ 2001;323:776-80.
-
(2001)
BMJ
, vol.323
, pp. 776-780
-
-
Wyatt, K.1
Dimmock, P.2
Jones, P.3
|